Published on 11 October 2012
A clinician’s view of the ethics of the use of biosimilars
Author(s): Dr Kalle Hoppu
DOI: 10.5639/gabij.2012.0103-4.035
9.278 views
Published on 11 October 2012
Author(s): Dr Kalle Hoppu
DOI: 10.5639/gabij.2012.0103-4.035
9.278 views
Published on 11 October 2012
Author(s): Carlo Petrini, PhD
bioethics, drugs, ethics committees, legislation, risk, safety
DOI: 10.5639/gabij.2012.0103-4.034
12.322 views
Published on 10 October 2012
Author(s): Sabine Vogler, PhD
generics policies, health professionals, patients, reference price system, reimbursement
DOI: 10.5639/gabij.2012.0103-4.031
12.853 views
Published on 20 August 2012
Author(s): Yuki Ando, BA, Toshiyoshi Tominaga, PhD, Tatsuya Kondo, MD, PhD
approval review, international strategy, Japanese regulatory authority, PMDA, regulatory science, safety measure
DOI: 10.5639/gabij.2013.0201.013
20.198 views
Published on 20 August 2012
Author(s): Christoph Baumgärtel, MD, MSc
cardiovascular risk, generics, inferiority, potency, statins
DOI: 10.5639/gabij.2012.0103-4.032
18.234 views
Published on 02 August 2012
Author(s): Andy Gray, MScPharm, FPS, FFIP
generics policies, transparency, WHO policy
DOI: 10.5639/gabij.2012.0103-4.027
26.525 views
Published on 01 August 2012
Author(s): Luc Besançon
counterfeit medicines, healthcare professionals, risk communication
DOI: 10.5639/gabij.2012.0103-4.026
14.923 views
Published on 01 August 2012
Author(s): Keith McDonald, MSc, MRPharmS, Kowid Ho, PhD
biotechnological and chemical substances, drug substance quality, ICH Q11
DOI: 10.5639/gabij.2012.0103-4.025
35.942 views
Published on 01 August 2012
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2012.0102.024
5.294 views
Published on 04 July 2012
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2012.0102.022
7.808 views
Published on 03 July 2012
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2012.0102.015
12.110 views
Published on 03 July 2012
Author(s): Meenu Wadhwa, PhD, Robin Thorpe, PhD, FRCPath
comparability, guidelines, non-innovator biologic, quality, safety
DOI: 10.5639/gabij.2012.0103-4.023
31.591 views